These observations, together with evidence from postmenopausal osteoporosis, inflammatory bone diseases, and metabolic disorders such as obesity and diabetes described in earlier sections, indicate that exogenous GIP modulates bone turnover across a broad spectrum of pathological contexts. The gene discussed is GIP; the disease is obesity due to melanocortin 4 receptor deficiency.